Ondansetron Injection
Product Images NDC 55154-2876

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 55154-2876). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Ondansetron Injection Usp Novaplus 1)

Structure (Ondansetron Injection Usp   Novaplus 1)
Chemical structure showing the molecular formula of Ondansetron hydrochloride dihydrate, the active ingredient in Ondansetron injection 2 mg/mL by Cardinal Health 107, LLC.*
FDA Label Image

4mg Per 2ml Bag Label (Image 01)

4mg Per 2ml Bag Label (Image 01)
Ondansetron Injection USP 4 mg per 2 mL (2 mg/mL) label for a package containing 5 single dose vials of 2 mL each. The label indicates the product is for IV or IM injection, sterile, and provides storage instructions along with manufacturer (Hikma) and distributor (Cardinal Health) details. It includes warnings and ingredients information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.